» Authors » Angela C M Luzo

Angela C M Luzo

Explore the profile of Angela C M Luzo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 74
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Luzo A, Favaro W, Seabra A, Duran N
Heliyon . 2020 Apr; 6(3):e03660. PMID: 32258495
Platelet-rich-plasma (PRP) is an autologous human platelet concentrate extracted from plasma. PRP has been investigated in order to be used in many fields, with emphasis on the musculoskeletal field applied...
2.
Zorzi A, Amstalden E, Plepis A, Martins V, Ferretti M, Antonioli E, et al.
Int J Mol Sci . 2015 Nov; 16(11):26813-31. PMID: 26569221
Cell therapy is a promising approach to improve cartilage healing. Adipose tissue is an abundant and readily accessible cell source. Previous studies have demonstrated good cartilage repair results with adipose...
3.
Ribeiro T, Duarte A, Longhini A, Pradella F, Farias A, Luzo A, et al.
Sci Rep . 2015 Nov; 5:16167. PMID: 26548646
The present study investigates the effects of xenotransplantation of Adipose Tissue Mesenchymal Stem Cells (AT-MSCs) in animals after ventral root avulsion. AT-MSC has similar characteristics to bone marrow mesenchymal stem...
4.
Perez A, Rodrigues A, Luzo A, Lana J, Belangero W, Santana M
J Mater Sci Mater Med . 2014 May; 25(8):1967-77. PMID: 24838297
Fibrin networks are obtained through activation of platelet-rich plasma (PRP) for use in tissue regeneration. The importance of fibrin networks relies on mediation of release of growth factors, proliferation of...
5.
Pereira-Cunha F, Duarte A, Costa F, Saad S, Lorand-Metze I, Luzo A
Transfusion . 2013 Jan; 53(9):2034-42. PMID: 23320473
Background: Umbilical cord blood (UCB) is a good source of hematopoietic stem cells for transplantation and cell therapy. In 2006, the Brazilian Public Network of Cord Blood Banks was founded;...
6.
Gilli S, Boin I, Leonardi L, Luzo A, Costa F, Saad S
Transplantation . 2002 Oct; 74(6):896-8. PMID: 12364877
Background: Patients presenting sickle cell disease may develop different types of hepatic complications. Intrahepatic cholestasis is a potentially fatal complication of the disease, and sometimes the only possible solution is...